Granulocyte-macrophage colony-stimulating factor

The Cytokine Handbook

Volumn , Issue , 2003, Pages 503-524

  Enzler, Thomas ^a,b   Dranoff, Glenn ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942905143     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012689663-3/50025-9     Document Type: Chapter

References (283)

1. Aglietta M., De Felice L., Stacchini A., et al. In vivo effect of granulocyte-macrophage colony-stimulating factor on the kinetics of human acute yeloid leukemia cells. Leukemia 1991, 5:979-984.
2. Akahane K., Cohen R.B., Bickel M., Pluznik D.H. IL-1 alpha induces granulocyte-macrophage colony-stimulating factor gene expression in murine B lymphocyte cell lines via mRNA stabilization. J. Immunol. 1991, 146:4190-4196.
3. Akashi M., Shaw G., Gross M., et al. Role of AUUU sequences in stabilization of granulocyte-macrophage colony-stimulating factor RNA in stimulated cells. Blood 1991, 78:2005-2012.
4. Akashi M., Shaw G., Hachiya M., et al. Number and location of AUUUA motifs: role in regulating transiently expressed RNAs. Blood 1994, 83:3182-3187.
5. Angel J.B., High K., Rhame F., et al. Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. Leukine/HIV Study Group. AIDS 2000, 14:387-395.
6. Armstrong C.A., Botella R., Galloway T.H., et al. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells. Cancer Res. 1996, 56:2191-2198.
7. Azam M., Erdjument-Bromage H., Kreider B.L., et al. Interleukin-3 signals through multiple isoforms of Stat5. EMBO J. 1995, 14:1402-1411.
8. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
9. Barraclough R.M., Gillies A.J. Pulmonary alveolar proteinosis: a complete response to GM-CSF therapy. Thorax 2001, 56:664-665.
10. Basu S., Dunn A.R., Marino M.W., et al. Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 1997, 159:1412-1417.
11. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl Acad. Sci. USA 1990, 87:6934-6938.
12. Bendall L.J., Kortlepel K., Gottlieb D.J. GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1. Leukemia 1995, 9:677-684.
13. Bendandi M., Gocke C.D., Kobrin C.B., et al. Complete molecular remissions induced by patientspecific vaccination plus granulocyte-monocyte colonystimulating factor against lymphoma. Nat. Med. 1999, 5:1171-1177.
14. Bennett C.L., Stinson T.J., Tallman M.S., et al. Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients, (>55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490). Ann. Oncol. 1999, 10:177-182.
15. Bergamini A., Bolacchi F., Bongiovanni B., et al. Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. Immunology 2000, 101:254-261.
16. Bernasconi S., Matteucci C., Sironi M., et al. Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages. Int. J. Cancer 1995, 60:300-307.
17. Bettelheim P., Valent P., Andreeff M., et al. Recombinant human granulocyte-macrophage colonystimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia. Blood 1991, 77:700-711.
18. Bickel M., Cohen R.B., Pluznik D.H. Post-transcriptional regulation of granulocyte-macrophage colony-stimulating factor synthesis in murine T cells. J. Immunol. 1990, 145:840-845.
19. Bilgin K., Yaramis A., Haspolat K., et al. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics 2001, 107:36-41.
20. Bodey G.P., Anaissie E., Gutterman J., Vadhan-Raj S. Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer. Clin. Infect. Dis. 1993, 17:705-707.
21. Bot FJ., van Eijk L., Schipper P., Lowenberg B. Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M. Exp. Hematol. 1989, 17:292-295.
22. Braunstein S., Kaplan G., Gottlieb A.B., et al. GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. J. Invest. Dermatol. 1994, 103:601-604.
23. Brizzi M.F., Zini M.G., Aronica M.G., et al. Convergence of signaling by interleukin-3, granulocyte-macrophage colony-stimulating factor, and mast cell growth factor on JAK2 tyrosine kinase. J. Biol. Chem. 1994, 269:31680-31684.
24. Brizzi M.F., Aronica M.G., Rosso A., et al. Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes. J. Biol. Chem. 1996, 271:3562-3567.
25. Broxmeyer H.E., Cooper S., Vadhan-Raj S. Cell cycle status of erythroid (BFU-E) progenitor cells from the bone marrows of patients on a clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Exp. Hematol. 1989, 17:455-459.
26. Brugger W., Bross K., Frisch J., et al. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. Blood 1992, 79:1193-1200.
27. Buchner T., Hiddemann W., Wormann B., et al. The role of GM-CSF in the treatment of acute myeloid leukemia. Leuk. Lymphoma 1993, 11:21-24.
28. Bussolino F., Wang J.M., Defilippi P., et al. Granulocyte- and granulocyte-macrophage colonystimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989, 337:471-473.
29. Buzby J.S., Lee S.M., Van Winkle P., et al. Increased granulocyte- macrophage colony-stimulating factor mRNA instability in cord versus adult mononuclear cells is translation-dependent and associated with increased levels of A+U-rich element binding factor. Blood 1996, 88:2889-2897.
30. Cakouros D., Cockerill P.N., Bert A.G., et al. A nf-kappab/sp1 region is essential for chromatin remodeling and correct transcription of a human granulocyte-macrophage colony-stimulating factor transgene. J. Immunol. 2001, 167:302-310.
31. Campbell I.K., Rich M.J., Bischof R.J., et al. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 1998, 161:3639-3644.
32. Campos L., Bastion Y., Roubi N., et al. Peripheral blood stem cells harvested after chemotherapy and GM-CSF for treatment intensification in patients with advanced lymphoproliferative diseases. Leukemia 1993, 7:1409-1415.
33. Cannistra S.A., Vellenga E., Groshek P., et al. Human granulocyte-monocyte colony-stimulating factor and interleukin-3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood 1988, 71:672-676.
34. Canturk N.Z., Vural B., Esen N., et al. Effects of granulocyte-macrophage colony-stimulating factor, on incisional wound healing in an experimental diabetic rat model. Endocr. Res. 1999, 25:105-116.
35. Carr R., Modi N., Dore C.J., et al. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation. Pediatrics 1999, 103:796-802.
36. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992, 360:258-261.
37. Caux C., Vanbervliet B., Massacrier C., et al. CD34+hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell, pathways in response to GM-CSF+TNF alpha. J. Exp. Med. 1996, 184:695-706.
38. Cebon J., Nicola N., Ward M., et al. Granulocyte-macrophage colony-stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activity. J. Biol. Chem. 1990, 265:4483-4491.
39. Chiang M.Y., Monroe J.G. Role for transcription pax5a factor in maintaining commitment to the B cell lineage by selective inhibition of granulocyte-macrophage colony-stimulating factor receptor expression. J. Immunol. 2001, 166:6091-6098.
40. Chiou C.J., Wu M.C. Expression of human granulocyte-macrophage colony-stimulating factor gene in insect cells by a baculovirus vector. FEBS Lett. 1990, 259:249-253.
41. Chopra R., Kendall G., Gale R.E., et al. Expression of two alternatively spliced forms of the 5' untranslated region of the GM-CSF receptor alpha chain mRNA. Exp. Hematol. 1996, 24:755-762.
42. Clark S.C., Kamen R. The human hematopoietic colony-stimulating factors. Science 1987, 236:1229-1237.
43. Clark-Lewis I., Lopez A.F., To L.B., et al. Structure-function studies of human granulocyte-macrophage colony-stimulating factor. Identification of residues required for activity. J. Immunol. 1988, 141:881-889.
44. Cockerill P.N., Shannon M.F., Bert A.G., et al. The granulocyte-macrophage colony-stimulating factor/interleukin-3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc. Natl. Acad. Sci. USA 1993, 90:2466-2470.
45. Cockerill P.N., Bert A.G., Jenkins F., et al. Human granulocyte-macrophage colony-stimulating factor enhancer function is associated with cooperative interactions between AP-1 and NFATp/c. Mol. Cell. Biol. 1995, 15:2071-2079.
46. Coles L.S., Diamond P., Occhiodoro F., et al. An ordered array of cold shock domain repressor elements across tumor necrosis factor-responsive elements of the granulocyte-macrophage colony-stimulating factor promoter. J. Biol. Chem. 2000, 275:14482-14493.
47. Collins H.L., Bancroft G.J. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol. 1992, 22:1447-1454.
48. Cooke K.R., Nishinakamura R., Martin T.R., et al. Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 beta c receptor-deficient mice despite correction of alveolar proteinosis after BMT. Bone Marrow Transplant 1997, 20:657-662.
49. da Costa R.M., Aniceto C., Jesus F.M., Mendes M. Quick healing of leg ulcers after molgramostim. Lancet 1994, 344:481-482.
50. Dedhar S., Gaboury L., Galloway P., Eaves C. Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin. Proc. Natl. Acad. Sci. USA 1988, 85:9253-9257.
51. Diederichs K., Jacques S., Boone T., Karplus P.A. Low-resolution structure of recombinant human granulocyte-macrophage colony-stimulating factor. J. Mol. Biol. 1991, 221:55-60.
52. Dirksen U., Nishinakamura R., Groneck P., et al. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J. Clin. Invest. 1997, 100:2211-2217.
53. Disis M.J., Grabstein K.H., Sleath P.R., Cheever M.A. Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine. Clin. Cancer Res. 1999, 5:1289-1297.
54. Donahue R.E., Wang E.A., Stone D.K., et al. Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature 1986, 321:872-875.
55. Donahue R.E., Seehra J., Metzger M., et al. Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science 1988, 241:1820-1823.
56. Doyle S.E., Gasson J.C. Characterization of the role of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit in the activation of JAK2 and STAT5. Blood 1998, 92:867-876.
57. Dranoff G. Cancer gene therapy: connecting basic research with clinical inquiry. J. Clin. Oncol. 1998, 16:2548-2556.
58. Dranoff G., Mulligan R.C. Activities of granulocyte-macrophage colony-stimulating factor revealed by gene transfer and gene knockout studies. Stem Cells 1994, 12:173-182. discussion 182-184.
59. Dranoff G., Jaffee E., Lazenby A., et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl Acad. Sci. USA 1993, 90:3539-3543.
60. Dranoff G., Crawford A.D., Sadelain M., et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994, 264:713-716.
61. Elliott M.J., Strasser A., Metcalf D. Selective upregulation of macrophage function in granulocytemacrophage colony-stimulating factor transgenic mice. J. Immunol. 1991, 147:2957-2963.
62. Ernst T.J., Ritchie A.R., O'Rourke R., Griffin J.D. Colony-stimulating factor gene expression in human acute myeloblastic leukemia cells is posttranscriptionally regulated. Leukemia 1989, 3:620-625.
63. Estey E.H. Use of colony-stimulating factors in the treatment of acute myeloid leukemia. Blood 1994, 83:2015-2019.
64. Falkenburg J.H., Harrington M.A., de Paus R.A., et al. Differential transcriptional and posttranscriptional regulation of gene expression of the colony-stimulating factors by interleukin-1 and fetal bovine serum in murine fibroblasts. Blood 1991, 78:658-665.
65. Ferrero D., Tarella C., Badoni R., et al. Granulocyte-macrophage colony-stimulating factor requires interaction with accessory cells or granulocyte colony-stimulating factor for full stimulation of human myeloid progenitors. Blood 1989, 73:402-405.
66. Finbloom D.S., Larner A.C., Nakagawa Y., Hoover D.L. Culture of human monocytes with granulocyte-macrophage colony-stimulating factor results in enhancement of IFN-gamma receptors but suppression of IFN-gamma-induced expression of the gene IP-10. J. Immunol. 1993, 150:2383-2390.
67. Fischer H.G., Frosch S., Reske K., Reske-Kunz A.B. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. J. Immunol. 1988, 141:3882-3888.
68. Fleischmann J., Golde D.W., Weisbart R.H., Gasson J.C. Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood 1986, 68:708-711.
69. Folks T.M., Justement J., Kinter A., et al. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987, 238:800-802.
70. Ford P.A., Arbuck S.G., Minniti C., et al. Phase I trial of etoposide, doxorubicin and cisplatin (EAP) in combination with GM-CSF. Eur. J. Cancer 1996, 32A:631-635.
71. Foster P.S., Hogan S.P., Ramsay A.J., et al. Interleukin-5 deficiency abolishes eosinophilia, air-ways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 1996, 183:195-201.
72. Frenette P.S., Desforges J.F., Schenkein D.P., et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming in the treatment of elderly patients with acute myelogenous leukemia. Am. J. Hematol. 1995, 49:48-55.
73. Fukunaga R., Seto Y., Mizushima S., Nagata S. Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. Proc. Natl Acad. Sci. USA 1990, 87:8702-8706.
74. Ganser A., Hoelzer D. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes. Semin. Hematol. 1996, 33:186-195.
75. Gasson J.C. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 1991, 77:1131-1145.
76. Gasson J.C., Weisbart R.H., Kaufman S.E., et al. Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. Science 1984, 226:1339-1342.
77. Gearing D.P., King J.A., Gough N.M., Nicola N.A. Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J. 1989, 8:3667-3676.
78. Gianni A.M., Siena S., Bregni M., et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989, 2:580-585.
79. Gianni A.M., Bregni M., Siena S., et al. Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J. Clin. Oncol. 1990, 8:768-778.
80. Gill P.S., Bernstein-Singer M., Espina B.M., et al. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma. AIDS 1992, 6:1477-1481.
81. Gillessen S., Mach N., Small C., et al. Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity. Blood 2001, 97:922-928.
82. Gorman D.M., Itoh N., Jenkins N.A., et al. Chromosomal localization and organization of the murine genes encoding the beta subunits (AIC2A and AIC2B) of the interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 receptors. J. Biol. Chem. 1992, 267:15842-15848.
83. Gough N.M., Gough J., Metcalf D., et al. Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony-stimulating factor. Nature 1984, 309:763-767.
84. Gough N.M., Metcalf D., Gough J., et al. Structure and expression of the mRNA for murine granulocyte-macrophage colony-stimulating factor. EMBO J. 1985, 4:645-653.
85. Gough N.M., Grail D., Gearing D.P., Metcalf D. Mutagenesis of murine granulocyte-macrophage colony-stimulating factor reveals critical residues near the N terminus. Eur. J. Biochem. 1987, 169:353-358.
86. Grabstein K.H., Urdal D.L., Tushinski R.J., et al. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 1986, 232:506-508.
87. Grem J.L., McAtee N., Murphy R.F., et al. Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma. J. Clin. Oncol. 1994, 12:560-568.
88. Groves R.W., Schmidt-Lucke J.A. Recombinant human GM-CSF in the treatment of poorly healing wounds. Adv. Skin Wound Care 2000, 13:107-112.
89. Gulati S.C., Bennett C.L. Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin disease. Ann. Intern. Med. 1992, 116:177-182.
90. Haak-Frendscho M., Arai N., Arai K., et al. Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin-3 cause basophil histamine release. J. Clin. Invest. 1988, 82:17-20.
91. Hahn S., Wodnar-Filipowicz A., Nair A.P., Moroni C. Ras oncogenes amplify lymphokine (interleukin-3, granulocyte-macrophage colony-stimulating factor) induction by calcium ionophore. Oncogene 1991, 6:2327-2332.
92. Hammer S.M., Gillis J.M. Synergistic activity of granulocyte-macrophage colony-stimulating factor and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro. Antimicrob. Agents Chemother. 1987, 31:1046-1050.
93. Hammer S.M., Gillis J.M., Pinkston P., Rose R.M. Effect of zidovudine and granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus replication in alveolar macrophages. Blood 1990, 75:1215-1219.
94. Hancock G.E., Kaplan G., Cohn Z.A. Keratinocyte growth regulation by the products of immune cells. J. Exp. Med. 1988, 168:1395-1402.
95. Hayashida K., Kitamura T., Gorman D.M., et al. Molecular cloning of a second subunit of the receptor for human granulocyte- macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc. Natl Acad. Sci. USA 1990, 87:9655-9659.
96. Hebert J.C., O'Reilly M. Granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances pulmonary defenses against pneumococcal infections after splenectomy. J. Trauma. 1996, 41:663-666.
97. Heil G., Chadid L., Hoelzer D., et al. GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia (AML). Leukemia 1995, 9:3-9.
98. Hejna M., Brodowicz T., Zielinski C.C. Local use of GM-CSF for severe mucositis. Eur. J. Cancer 1999, 35(Suppl. 3):S14-S17.
99. Hess G., Kreiter F., Kosters W., Deusch K. The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on hepatitis B vaccination in haemodialysis patients. J. Viral Hepat. 1996, 3:149-153.
100. Hirai K., Morita Y., Misaki Y., et al. Modulation of human basophil histamine release by hemopoietic growth factors. J. Immunol. 1988, 141:3958-3964.
101. Hu X., Zuckerman K.S. Cloning and sequencing of an alternative splicing-derived cDNA variant of the GM-CSF receptor alpha subunit, which encodes a truncated protein. Am. J. Hematol. 1998, 58:145-147.
102. Hu X., Emanuel P.D., Zuckerman K.S. Cloning and sequencing of the cDNAs encoding two alternative splicing-derived variants of the alpha subunit of the granulocyte-macrophage colony-stimulating factor receptor. Biochim. Biophys. Acta 1994, 1223:306-308.
103. Huffman J.A., Hull W.M., Dranoff G., et al. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J. Clin. Invest. 1996, 97:649-655.
104. Ikegami M., Ueda T., Hull W., et al. Surfactant metabolism in transgenic mice after granulocyte-macrophage colony-stimulating factor ablation. Am. J. Physiol. 1996, 270:L650-L658.
105. Ikegami M., Hull W.M., Yoshida M., et al. SP-D and GM-CSF regulate surfactant homeostasis via distinct mechanisms. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 281:L697-L703.
106. Inaba K., Steinman R.M., Pack M.W., et al. Identification of proliferating dendritic cell precursors in mouse blood. J. Exp. Med. 1992, 175:1157-1167.
107. Itoh T., Muto A., Watanabe S., et al. Granulocyte-macrophage colony-stimulating factor provokes RAS activation and transcription of c-fos through different modes of signaling. J. Biol. Chem. 1996, 271:7587-7592.
108. Iwai Y., Bickel M., Pluznik D.H., Cohen R.B. Identification of sequences within the murine granulocyte-macrophage colony-stimulating factor mRNA 3'-untranslated region that mediate mRNA stabilization induced by mitogen treatment of EL-4 thymoma cells. J. Biol. Chem. 1991, 266:17959-17965.
109. Jager E., Ringhoffer M., Dienes H.P., et al. Granulocyte-macrophage colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int. J. Cancer 1996, 67:54-62.
110. Jaschke E., Zabernigg A., Gattringer C. Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers. Int. J. Dermatol. 1999, 38:380-386.
111. Jenkins F., Cockerill P.N., Bohmann D., Shannon M.F. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells. J. Immunol. 1995, 155:1240-1251.
112. Johnson G.R., Gonda T.J., Metcalf D., et al. A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony-stimulating factor. EMBO J. 1989, 8:441-448.
113. Jones T.C. Future uses of granulocyte-macrophage colony-stimulating factor (GM-CSF). Stem Cells 1994, 12:229-239. discussion 239-240.
114. Jones T.C. The effect of granulocyte-macrophage colony-stimulating factor (rGM-CSF) on macrophage function in microbial disease. Med. Oncol. 1996, 13:141-147.
115. Jyung R.W., Wu L., Pierce G.F., Mustoe T.A. Granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: differential action on incisional wound healing. Surgery 1994, 115:325-334.
116. Kanz L., Brugger W., Mertelsmann R. Haematopoietic growth factors and peripheral blood stem cells as supportive agents in dose intensification. Eur. J. Cancer 1993, 29A:S23-S26.
117. Kaplan S.S., Basford R.E., Wing E.J., Shadduck R.K. The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutrophil activation in patients with refractory carcinoma. Blood 1989, 73:636-638.
118. Kaplan G., Walsh G., Guido L.S., et al. Novel responses of human skin to intradermal recombinant granulocyte-macrophage colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J. Exp. Med. 1992, 175:1717-1728.
119. Karthaus M., Rosenthal C., Ganser A. Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis-are there new strategies?. Bone Marrow Transplant. 1999, 24:1095-1108.
120. Kaushansky K. Control of granulocyte-macrophage colony-stimulating factor production in normal endothelial cells by positive and negative regulatory elements. J. Immunol. 1989, 143:2525-2529.
121. Kaushansky K., O'Hara P.J., Hart C.E., et al. Role of carbohydrate in the function of human granulocyte-macrophage colony-stimulating factor. Biochemistry 1987, 26:4861-4867.
122. Kaushansky K., Shoemaker S.G., Alfaro S., Brown C. Hematopoietic activity of granulocyte-macrophage colony-stimulating factor is dependent upon two distinct regions of the molecule: functional analysis based upon the activities of interspecies hybrid growth factors. Proc. Natl Acad. Sci. USA 1989, 86:1213-1217.
123. Kavuru M.S., Sullivan E.J., Piccin R., et al. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am. J. Respir. Crit. Care Med. 2000, 161:1143-1148.
124. Kedzierska K., Mak J., Mijch A., et al. Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo. J. Infect. Dis. 2000, 181:390-394.
125. Kitamura T., Sato N., Arai K., Miyajima A. Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 1991, 66:1165-1174.
126. Kitamura T., Tanaka N., Watanabe J., et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocytemacrophage colony-stimulating factor. J. Exp. Med. 1999, 190:875-880.
127. Kitano K., Abboud C.N., Ryan D.H., et al. Macrophage-active colony-stimulating factors enhance human immunodeficiency virus type 1 infection in bone marrow stem cells. Blood 1991, 77:1699-1705.
128. Kleinerman E.S., Knowles R.D., Lachman L.B., Gutterman J.U. Effect of recombinant granulocyte-macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration. Cancer Res. 1988, 48:2604-2609.
129. Koeffler H.P., Gasson J., Tobler A. Transcriptional and posttranscriptional modulation of myeloid colony-stimulating factor expression by tumor necrosis factor and other agents. Mol. Cell. Biol. 1988, 8:3432-3438.
130. Koyanagi Y., O'Brien W.A., Zhao J.Q., et al. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 1988, 241:1673-1675.
131. Koyano-Nakagawa N., Nishida J., Arai N., et al. Reconstitution of the functional granulocyte-macrophage colony-stimulating factor promoter: evidence for distinct activation mechanisms that mediate the response to phorbol ester/calcium and human T cell leukemia virus type I Tax signals. Int. Immunol. 1993, 5:345-352.
132. Kremer E., Baker E., D'Andrea R.J., et al. A cytokine receptor gene cluster in the X-Y pseudoautosomal region?. Blood 1993, 82:22-28.
133. Kruger M., Van Gool S., Peng X.H., et al. Production of granulocyte-macrophage colony-stimulating factor by T cells is regulated by B7 and IL-1 beta. Immunology 1996, 88:49-54.
134. LaBranche C.C., Clark S.C., Johnson G.D., et al. Deletion of carboxy-terminal residues of murine granulocyte-macrophage colony-stimulating factor results in a loss of biologic activity and altered glycosylation. Arch. Biochem. Biophys. 1990, 276:153-159.
135. Lachance D.H., Oette D., Schold S.C., et al. Dose escalation trial of cyclophosphamide with Sargramostim in the treatment of central nervous system (CNS) neoplasms. Med. Pediatr. Oncol. 1995, 24:241-247.
136. Lai W.S., Blackshear P.J. Interactions of CCCH zinc finger proteins with mRNA: tristetraprolin-mediated AU-rich element-dependent mRNA degradation can occur in the absence of a poly(A) tail. J. Biol. Chem. 2001, 276:23144-23154.
137. Lai W.S., Carballo E., Thorn J.M., et al. Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA. J. Biol. Chem. 2000, 275:17827-17837.
138. Lane T.A., Law P., Maruyama M., et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995, 85:275-282.
139. Lang R.A., Metcalf D., Cuthbertson R.A., et al. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell 1987, 51:675-686.
140. Le Beau M.M., Pettenati M.J., Lemons R.S., et al. Assignment of the GM-CSF, CSF-1, and FMS genes to human chromosome 5 provides evidence for linkage of a family of genes regulating hematopoiesis and for their involvement in the deletion (5q) in myeloid disorders. Cold Spring Harb. Symp. Quant. Biol. 1986, 51:899-909.
141. Lee F., Yokota T., Otsuka T., et al. Isolation of cDNA for a human granulocyte-macrophage colony-stimulating factor by functional expression in mammalian cells. Proc. Natl Acad. Sci. USA 1985, 82:4360-4364.
142. Leong S.P., Enders-Zohr P., Zhou Y.M., et al. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic melanoma. J. Immunother. 1999, 22:166-174.
143. LeVine A.M., Reed J.A., Kurak K.E., et al. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. J. Clin. Invest. 1999, 103:563-569.
144. Libby R.T., Braedt G., Kronheim S.R., et al. Expression and purification of native human granulocyte-macrophage colony-stimulating factor from an Escherichia coli secretion vector. DNA 1987, 6:221-229.
145. Liehl E., Hildebrandt J., Lam C., Mayer P. Prediction of the role of granulocyte-macrophage colony-stimulating factor in animals and man from in vitro results. Eur. J. Clin. Microbiol. Infect. Dis. 1994, 13:S9-S17.
146. Lieschke G.J., Stanley E., Grail D., et al. Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease. Blood 1994, 84:27-35.
147. Lilly M.B., Zemskova M., Frankel A.E., et al. Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit mediate activation of Jak/Stat signaling and differentiation. Blood 2001, 97:1662-1670.
148. Lopez A.F., Williamson D.J., Gamble J.R., et al. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J. Clin. Invest. 1986, 78:1220-1228.
149. Lopez A.F., Shannon M.F., Hercus T., et al. Residue 21 of human granulocyte-macrophage colony-stimulating factor is critical for biological activity and for high but not low affinity binding. EMBO J. 1992, 11:909-916.
150. Mach N., Gillessen S., Wilson S.B., et al. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res. 2000, 60:3239-3246.
151. Maliszewski C.R., Schoenborn M.A., Cerretti D.P., et al. Bovine GM-CSF: molecular cloning and biological activity of the recombinant protein. Mol. Immunol. 1988, 25:843-850.
152. Matsuda S., Akagawa K., Honda M., et al. Suppression of HIV replication in human monocyte-derived macrophages induced by granulocyte-macrophage colony-stimulating factor. AIDS Res. Hum. Retrovir. 1995, 11:1031-1038.
153. Mayer P., Lam C., Obenaus H., et al. Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates. Blood 1987, 70:206-213.
154. McKenna H.J., Stocking K.L., Miller R.E., et al. Mice lacking flt3-ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000, 95:3489-3497.
155. Metcalf D., Begley C.G., Williamson D.J., et al. Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp. Hematol. 1987, 15:1-9.
156. Migliaccio G., Migliaccio A.R., Adamson J.W. In vitro differentiation of human granulocyte-macrophage and erythroid progenitors: comparative analysis of the influence of recombinant human erythropoietin, G-CSF, GM-CSF, and IL-3 in serum-supplemented and serum-deprived cultures. Blood 1988, 72:248-256.
157. Miyatake S., Otsuka T., Yokota T., et al. Structure of the chromosomal gene for granulocyte-macrophage colony-stimulating factor: comparison of the mouse and human genes. EMBO J. 1985, 4:2561-2568.
158. Miyatake S., Shlomai J., Arai K., Arai N. Characterization of the mouse granulocyte-macrophage colony-stimulating factor (GM-CSF) gene promoter: nuclear factors that interact with an element shared by three lymphokine genes-those for GM-CSF, interleukin-4 (IL-4), and IL-5. Mol. Cell. Biol. 1991, 11:5894-5901.
159. Moghrabi A., Fuchs H., Brown M., et al. Cyclophosphamide in combination with sargramostim for treatment of recurrent medulloblastoma. Med. Pediatr. Oncol. 1995, 25:190-196.
160. Molloy R.G., Holzheimer R., Nestor M., et al. Granulocyte-macrophage colony-stimulating factor modulates immune function and improves survival after experimental thermal injury. Br. J. Surg. 1995, 82:770-776.
161. Monroy R.L., Skelly R.R., MacVittie T.J., et al. The effect of recombinant GM-CSF on the recovery of monkeys transplanted with autologous bone marrow. Blood 1987, 70:1696-1699.
162. Morrissey P.J., Bressler L., Park L.S., et al. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J. Immunol. 1987, 139:1113-1119.
163. Morrissey P.J., Grabstein K.H., Reed S.G., Conlon P.J. Granulocyte-macrophage colony-stimulating factor. A potent activation signal for mature macrophages and monocytes. Int. Arch. Allergy Appl. Immunol. 1989, 88:40-45.
164. Mui A.L., Wakao H., Harada N., et al. Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STAT5. J. Leukoc. Biol. 1995, 57:799-803.
165. Muto A., Watanabe S., Miyajima A., et al. The beta subunit of human granulocyte-macrophage colony-stimulating factor receptor forms a homodimer and is activated via association with the alpha subunit. J. Exp. Med. 1996, 183:1911-1916.
166. Nakagawa Y., Kosugi H., Miyajima A., et al. Structure of the gene encoding the alpha subunit of the human granulocyte-macrophage colony-stimulating factor receptor. Implications for the evolution of the cytokine receptor superfamily. J. Biol. Chem. 1994, 269:10905-10912.
167. Naora H., van Leeuwen B.H., Bourke P.F., Young I.G. Functional role and signal-induced modulation of proteins recognizing the conserved TCATTT-containing promoter elements in the murine IL-5 and GM-CSF genes in T lymphocytes. J. Immunol. 1994, 153:3466-3475.
168. Neidhart J.A., Mangalik A., Stidley C.A., et al. Dosing regimen of granulocyte-macrophage colony-stimulating factor to support dose-intensive chemotherapy. J. Clin. Oncol. 1992, 10:1460-1469.
169. Nemunaitis J., Singer J.W., Buckner C.D., et al. Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation. Blood 1990, 76:245-253.
170. Nemunaitis J., Rabinowe S.N., Singer J.W., et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N. Engl. J. Med. 1991, 324:1773-1775.
171. Nicola N.A., Burgess A.W., Metcalf D. Similar molecular properties of granulocyte-macrophage colony-stimulating factors produced by different mouse organs in vitro and in vivo. J. Biol. Chem. 1979, 254:5290-5299.
172. Nienhuis A.W., Donahue R.E., Karlsson S., et al. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J. Clin. Invest. 1987, 80:573-577.
173. Nimer S.D., Morita E.A., Martis M.J., et al. Characterization of the human granulocyte-macrophage colony-stimulating factor promoter region by genetic analysis: correlation with DNase I footprinting. Mol. Cell. Biol. 1988, 8:1979-1984.
174. Nimer S., Fraser J., Richards J., et al. The repeated sequence CATT(A/T) is required for granulocyte-macrophage colony-stimulating factor promoter activity. Mol. Cell. Biol. 1990, 10:6084-6088.
175. Nishinakamura R., Nakayama N., Hirabayashi Y., et al. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. Immunity 1995, 2:211-222.
176. Nishinakamura R., Miyajima A., Mee P.J., et al. Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions. Blood 1996, 88:2458-2464.
177. Nishinakamura R., Wiler R., Dirksen U., et al. The pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor/interleukins-3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation. J. Exp. Med. 1996, 183:2657-2662.
178. Noguchi Y., Wada H., Marino M.W., Old L.J. Regulation of IFN-gamma production in granulocyte-macrophage colony-stimulating factor-deficient mice. Eur. J. Immunol. 1998, 28:3980-3988.
179. Okuda K., Sanghera J.S., Pelech S.L., et al. Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase. Blood 1992, 79:2880-2887.
180. Onyeji C.O., Nightingale C.H., Tessier P.R., et al. Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-intracellulare. J. Infect. Dis. 1995, 172:810-816.
181. Operschall E., Schuh T., Heinzerling L., et al. Enhanced protection against viral infection by coadministration of plasmid DNA coding for viral antigen and cytokines in mice. J. Clin. Virol. 1999, 13:17-27.
182. Owen W.F., Rothenberg M.E., Silberstein D.S., et al. Regulation of human eosinophil viability, density, and function by granulocyte-macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J. Exp. Med. 1987, 166:129-141.
183. Paine R., Preston A.M., Wilcoxen S., et al. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J. Immunol. 2000, 164:2602-2609.
184. Pauksen K., Linde A., Hammarstrom V., et al. Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clin. Infect. Dis. 2000, 30:342-348.
185. Perno C.F., Cooney D.A., Gao W.Y., et al. Effects of bone marrow stimulatory cytokines on human immun-odeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages. Blood 1992, 80:995-1003.
186. Pfreundschuh M., Hasenclever D., Loeffler M., et al. Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF. Ann. Oncol. 2001, 12:471-477.
187. Price V., Mochizuki D., March C.J., et al. Expression, purification and characterization of recombinant murine granulocyte-macrophage colony-stimulating factor and bovine interleukin-2 from yeast. Gene 1987, 55:287-293.
188. Quelle F.W., Sato N., Witthuhn B.A., et al. JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol. 1994, 14:4335-4341.
189. Raderer M., Kornek G., Hejna M., et al. Topical granulocyte-macrophage colony-stimulating factor in patients with cancer and impaired wound healing. J. Natl. Cancer Inst. 1997, 89:263.
190. Raines M.A., Liu L., Quan S.G., et al. Identification and molecular cloning of a soluble human granulocyte-macrophage colony-stimulating factor receptor. Proc. Natl Acad. Sci. USA 1991, 88:8203-8207.
191. Rappold G., Willson T.A., Henke A., Gough N.M. Arrangement and localization of the human GM-CSF receptor alpha chain gene CSF2RA within the X-Y pseudoautosomal region. Genomics 1992, 14:455-461.
192. Reed S.G., Nathan C.F., Pihl D.L., et al. Recombinant granulocyte-macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma. J. Exp. Med. 1987, 166:1734-1746.
193. Reed J.A., Ikegami M., Robb L., et al. Distinct changes in pulmonary surfactant homeostasis in common beta chain- and GM-CSF-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 278:L1164-L1171.
194. Reid C.D., Stackpoole A., Meager A., Tikerpae J. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J. Immunol. 1992, 149:2681-2688.
195. Remes K., Ronnemaa T. Healing of chronic leg ulcers in diabetic necrobiosis lipoidica with local granulocyte-macrophage colony-stimulating factor treatment. J. Diabetes Complications 1999, 13:115-118.
196. Richard C., Baro J., Bello-Fernandez C., et al. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) administration after autologous bone marrow transplantation for acute myeloblastic leukemia enhances activated killer cell function and may diminish leukemic relapse. Bone Marrow Transplant. 1995, 15:721-726.
197. Riikonen P., Saarinen U.M., Makipernaa A., et al. Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double blind placebo-controlled study in children. Pediatr. Infect. Dis. J. 1994, 13:197-202.
198. Robertson S.A., Roberts C.T., Farr K.L., et al. Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice. Biol. Reprod. 1999, 60:251-261.
199. Robinson D.S., Durham S.R., Kay A.B. Cytokines. 3. Cytokines in asthma. Thorax 1993, 48:845-853.
200. Romani N., Gruner S., Brang D., et al. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994, 180:83-93.
201. Rossman M.D., Ruiz P., Comber P., et al. Modulation of macrophage Fc gamma receptors by rGM-CSF. Exp. Hematol. 1993, 21:177-183.
202. Rowe J.M., Rubin A., Mazza J.J., et al. Incidence of infections in adult patients (>55 years) with acute myeloid leukemia treated with yeast-derived GM-CSF (sargramostim): Results of a double-blind prospective study by the eastern Cooperative Oncology Group. Acute Leukemias V: Experimental Approaches and Management of Refractory Disease 1996, 178-198. Springer Verlag, Berlin. W. Hiddemann, T. Buchner, B. Wormann, L. Schellong, J. Ritter, U. Creutzig (Eds.).
203. Rozwarski D.A., Diederichs K., Hecht R., et al. Refined crystal structure and mutagenesis of human granulocyte-macrophage colony-stimulating factor. Proteins 1996, 26:304-313.
204. Ruef C., Coleman D.L. Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness. Rev. Infect. Dis. 1990, 12:41-62.
205. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte-macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994, 179:1109-1118.
206. Samanci A., Yi Q., Fagerberg J., et al. Pharmacological administration of granulocyte-macrophage colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcino-embryonic antigen. Cancer Immunol. Immunother. 1998, 47:131-142.
207. Santoli D., Clark S.C., Kreider B.L., et al. Amplification of IL-2-driven T cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony-stimulating factor. J. Immunol. 1988, 141:519-526.
208. Sato H., Nakayama T., Tanaka Y., et al. Induction of differentiation of pre-NKT cells to mature Valpha14 NKT cells by granulocyte-macrophage colony-stimulating factor. Proc. Natl Acad. Sci. USA 1999, 96:7439-7444.
209. Sato N., Sakamaki K., Terada N., et al. Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. EMBO J. 1993, 12:4181-4189.
210. Saunders D., Lucas K., Ismaili J., et al. Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte-macrophage colony-stimulating factor. J. Exp. Med. 1996, 184:2185-2196.
211. Scadden D.T., Bering H.A., Levine J.D., et al. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon-alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma. J. Clin. Oncol. 1991, 9:802-808.
212. Scadden D.T., Pickus O., Hammer S.M., et al. Lack of in vivo effect of granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 1996, 12:1151-1159.
213. Scheicher C., Mehlig M., Zecher R., Reske K. Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. Methods 1992, 154:253-264.
214. Schreck R., Baeuerle P.A. NF-kappa B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene. Mol. Cell. Biol. 1990, 10:1281-1286.
215. Schrimsher J.L., Rose K., Simona M.G., Wingfield P. Characterization of human and mouse granulocyte-macrophage colony-stimulating factors derived from Escherichia coli. Biochem. J. 1987, 247:195-199.
216. Schwinghammer T.L., Shadduck R.K., Waheed A., et al. Pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor after intravenous infusion and subcutaneous injection. Pharmacotherapy 1991, 2:105-108. (Abstr. 60).
217. Scott C.L., Hughes D.A., Cary D., et al. Functional analysis of mature hematopoietic cells from mice lacking the beta-c chain of the granulocyte-macrophage colony-stimulating factor receptor. Blood 1998, 92:4119-4127.
218. Segal G.M., McCall E., Bagby G.C. Erythroid burst-promoting activity produced by interleukin-1 stimulated endothelial cells is granulocyte-macrophage colony-stimulating factor. Blood 1988, 72:1364-1367.
219. Seymour J.F., Dunn A.R., Vincent J.M., et al. Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis. N. Engl. J. Med. 1996, 335:1924-1925.
220. Seymour J.F., Lieschke G.J., Grail D., et al. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood 1997, 90:3037-3049.
221. Shanafelt A.B., Kastelein R.A. Identification of critical regions in mouse granulocyte-macrophage colony-stimulating factor by scanning-deletion analysis. Proc. Natl Acad. Sci. USA 1989, 86:4872-4876.
222. Shanafelt A.B., Johnson K.E., Kastelein R.A. Identification of critical amino acid residues in human and mouse granulocyte-macrophage colony-stimulating factor and their involvement in species specificity. J. Biol. Chem. 1991, 266:13804-13810.
223. Shanafelt A.B., Miyajima A., Kitamura T., Kastelein R.A. The amino-terminal helix of GM-CSF and IL-5 governs high affinity binding to their receptors. EMBO J. 1991, 10:4105-4112.
224. Shannon M.F., Gamble J.R., Vadas M.A. Nuclear proteins interacting with the promoter region of the human granulocyte-macrophage colony-stimulating factor gene. Proc. Natl Acad. Sci. USA 1988, 85:674-678.
225. Zhao Z., Chu Y., Zhang Y., et al. Treatment of severe aplastic anemia with an immunosuppressive agent plus recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin. Am. J. Hematol. 1998, 59:185-191.
226. Shaw G., Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986, 46:659-667.
227. Shen Y., Baker E., Callen D.F., et al. Localization of the human GM-CSF receptor beta chain gene (CSF2RB) to chromosome 22q12.2→q13.1. Cytogenet. Cell. Genet. 1992, 61:175-177.
228. Sieff C.A., Emerson S.G., Donahue R.E., et al. Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin. Science 1985, 230:1171-1173.
229. Silberstein D.S., Owen W.F., Gasson J.C., et al. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J. Immunol. 1986, 137:3290-3294.
230. Skowron G., Stein D., Drusano G., et al. The safety and efficacy of granulocyte-macrophage colony-stimulating factor (Sargramostim) added to indinavir-or ritonavir-based antiretroviral therapy: a randomized double-blind, placebo-controlled trial. J. Infect. Dis. 1999, 180:1064-1071.
231. Slack J.L., Nemunaitis J., Andrews D.F., Singer J.W. Regulation of cytokine and growth factor gene expression in human bone marrow stromal cells transformed with simian virus 40. Blood 1990, 75:2319-2327.
232. Socinski M.A., Cannistra S.A., Elias A., et al. Granulocyte-macrophage colony-stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1988, 1:1194-1198.
233. Socinski M.A., Cannistra S.A., Sullivan R., et al. Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in vivo. Blood 1988, 72:691-697.
234. Soiffer R., Lynch T., Mihm M., et al. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc. Natl Acad. Sci. USA 1998, 95:13141-13146.
235. Sparrow L.G., Metcalf D., Hunkapiller M.W., et al. Purification and partial amino acid sequence of asialo murine granulocyte-macrophage colony-stimulating factor. Proc. Natl Acad. Sci. USA 1985, 82:292-296.
236. Spitler L.E., Grossbard M.L., Ernstoff M.S., et al. Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J. Clin. Oncol. 2000, 18:1614-1621.
237. Sprikkelman A., de Wolf J.T., Vellenga E. The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases. Leukemia 1994, 8:2031-2036.
238. Stahl C.P., Winton E.F., Monroe M.C., et al. Differential effects of sequential, simultaneous, and single agent interleukin-3 and granulocyte-macrophage colony-stimulating factor on megakaryocyte maturation and platelet response in primates. Blood 1992, 80:2479-2485.
239. Stankova J., Rola-Pleszczynski M., Dubois C.M. Granulocyte-macrophage colony-stimulating factor increases 5-lipoxygenase gene transcription and protein expression in human neutrophils. Blood 1995, 85:3719-3726.
240. Stanley E., Lieschke G.J., Grail D., et al. Granulocyte-macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl Acad. Sci. USA 1994, 91:5592-5596.
241. Stasi R., Pagano A., Terzoli E., Amadori S. Recombinant human granulocyte-macrophage colony-stimulating factor plus erythropoietin for the treatment of cytopenias in patients with myelodysplastic syndromes. Br. J. Haematol. 1999, 105:141-148.
242. Stern A.C., Jones T.C. The side-effect profile of GM-CSF. Infection 1992, 20:S124-S127.
243. Steward W.P., von Pawel J., Gatzemeier U., et al. Effects of granulocyte-macrophage colony-stimuating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients. J. Clin. Oncol. 1998, 16:642-650.
244. Stone R.M., Berg D.T., George S.L., et al. Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine. Blood 2001, 98:548-553.
245. Straneva J.E., Briddell R.A., McDonald T.P., et al. Effects of thrombocytopoiesis-stimulating factor on terminal cytoplasmic maturation of human megakaryocytes. Exp. Hematol. 1989, 17:1122-1127.
246. Stute N., Furman W.L., Schell M., Evans W.E. Pharmacokinetics of recombinant human granulocytemacrophage colony-stimulating factorin children after intravenous and subcutaneous administration. J. Pharm. Sci. 1995, 84:824-828.
247. Sung K.L., Li Y., Elices M., Gang J., et al. Granulocyte-macrophage colony-stimulating factor regulates the functional adhesive state of very late antigen-4 expressed by eosinophils. J. Immunol. 1997, 158:919-927.
248. Tarr P.E., Lin R., Mueller E.A., et al. Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine. Vaccine 1996, 14:1199-1204.
249. Tavernier J., Devos R., Cornelis S., et al. A human high affinity interleukin-5 receptor (IL5R) is a composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 1991, 66:1175-1184.
250. Tchou-Wong K.M., Harkin T.J., Chi C., et al. GM-CSF gene expression is normal but protein release is absent in a patient with pulmonary alveolar proteinosis. Am. J. Respir. Crit. Care Med. 1997, 156:1999-2002.
251. Thomas X., Fenaux P., Dombret H., et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial). Leukemia 1999, 13:1214-1220.
252. Thomassen M.J., Yi T., Raychaudhuri B., Malur A., Kavuru M.S. Pulmonary alveolar proteinosis is a an intrinsic cellular defect. Clin. Immunol. 2000, 95:85-92.
253. Thompson J.A., Gilliland D.G., Prchal J.T., et al. Effect of recombinant human erythropoietin combined with granulocyte-macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome. GM/EPO MDS Study Group. Blood 2000, 95:1175-1179.
254. Thorens B., Mermod J.J., Vassalli P. Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation. Cell 1987, 48:671-679.
255. Ulich T.R., del Castillo J., NcNiece I., et al. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow. Am. J. Pathol. 1990, 137:369-376.
256. Vadas M.A., Nicola N.A., Metcalf D. Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors. J. Immunol. 1983, 130:795-799.
257. Vadhan-Raj S., Keating M., LeMaistre A., et al. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N. Engl. J. Med. 1987, 317:1545-1552.
258. Vellenga E., Young D.C., Wagner K., et al. The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood 1987, 69:1771-1776.
259. Verhoef G., Boogaerts M. In vivo administration of granulocyte-macrophage colony stimulating factor enhances neutrophil function in patients with myelodys-plastic syndromes. Br. J. Haematol. 1991, 79:177-184.
260. Vremec D., Lieschke G.J., Dunn A.R., et al. The influence of granulocyte-macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur J. Immunol. 1997, 27:40-44.
261. Vyalov S., Desmouliere A., Gabbiani G. GM-CSF-induced granulation tissue formation: relationships between macrophage and myofibroblast accumulation. Virch. Arch. B Cell Pathol. Incl. Mol. Pathol. 1993, 63:231-239.
262. Wada H., Noguchi Y., Marino M.W., et al. T cell functions in granulocyte-macrophage colony-stimulating factor deficient mice. Proc. Natl Acad. Sci. USA 1997, 94:12557-12561.
263. Walker C., Bauer W., Braun R.K., et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am. J. Respir. Crit. Care Med. 1994, 150:1038-1048.
264. Wang J., Snider D.P., Hewlett B.R., et al. Transgenic expression of granulocyte-macrophage colony stimulating factor induces the differentiation and activation of a novel dendritic cell population in the lung. Blood 2000, 95:2337-2345.
265. Wang Y., Morella K.K., Ripperger J., et al. Receptors for interleukin-3 (IL-3) and growth hormone mediated an IL-6-type transcriptional induction in the presence of JAK2 or STAT3. Blood 1995, 86:1671-1679.
266. Watanabe S., Itoh T., Arai K. JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation through the human granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells. J. Biol. Chem. 1996, 271:12681-12686.
267. Weisbart R.H., Kacena A., Schuh A., Golde D.W. GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature 1988, 332:647-648.
268. Williams M.A., Kelsey S.M., Collins P.W., et al. Administration of rHuGM-CSF activates monocyte reactive oxygen species secretion and adhesion molecule expression in vivo in patients following high-dose chemotherapy. Br. J. Haematol. 1995, 90:31-40.
269. Wing E.J., Magee D.M., Whiteside T.L., et al. Recombinant human granulocyte-macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients. Blood 1989, 73:643-646.
270. Wingfield P., Graber P., Moonen P., et al. The conformation and stability of recombinant-derived granulocyte-macrophage colony-stimulating factors. Eur. J. Biochem. 1988, 173:65-72.
271. Witmer-Pack M.D., Olivier W., Valinsky J., et al. Granulocyte-macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med. 1987, 166:1484-1498.
272. Wong G., Witek J.S., Temple P.A., et al. Cancer Cells 1985, 235-242. Cold Spring Harbor Laboratory Press, New York. J. Feramisco, B. Ozanne, C. Stiles (Eds.).
273. Wong G.G., Witek J.S., Temple P.A., et al. Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 1985, 228:810-815.
274. Woodcock J.M., Bagley C.J., Zacharakis B., Lopez A.F. A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptor common beta-chain is necessary and sufficient for high affinity binding and signaling by all three ligands. J. Biol. Chem. 1996, 271:25999-26006.
275. Xing Z., Braciak T., Ohkawara Y., et al. Gene transfer for cytokine functional studies in the lung: the multifunctional role of GM-CSF in pulmonary inflammation. J. Leuk. Biol. 1996, 59:481-488.
276. Yang Y.C., Kovacic S., Kriz R., et al. The human genes for GM-CSF and IL 3 are closely linked in tandem on chromosome 5. Blood 1988, 71:958-961.
277. Yasukawa H., Sasaki A., Yoshimura A. Negative regulation of cytokine signaling pathways. Annu. Rev. Immunol. 2000, 18:143-164.
278. Yau J.C., Neidhart J.A., Triozzi P., et al. Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin. Am. J. Hematol. 1996, 51:289-295.
279. Yong K.L., Linch D.C. Granulocyte-macrophage colony-stimulating factor differentially regulates neutrophil migration across IL-1-activated and non-activated human endothelium. J. Immunol. 1994, 150:2449-2456.
280. Yoshida Y., Nakahata T., Shibata A., et al. Effects of long-term treatment with recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome. Leuk. Lymphoma 1995, 18:457-463.
281. Zhan Y., Lieschke G.J., Grail D., et al. Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenesis-infected mice. Blood 1998, 91:863-869.
282. Zhan Y., Basu S., Lieschke G.J., et al. Functional deficiencies of peritoneal cells from gene-targeted mice lacking G-CSF or GM-CSF. J. Leuk. Biol. 1999, 65:256-264.
283. Zhou L.J., Tedder T.F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl Acad. Sci. USA 1996, 93:2588-2592.